CIK 0000887359 · Large accelerated filer
Vericel Corp
Sign in to watch- Ticker
- VCEL
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- MI
- Entity type
- operating
- EIN
- 943096597
- Phone
- 6175885555
- Business address
- 25 BLUE SKY DRIVE, BURLINGTON, MA, 01803
- Former names
- AASTROM BIOSCIENCES INC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $5,787,802
- in 7 filings, $5.8M under 10b5-1 plans
Net −$5,787,802. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
- Mara Joseph Anthony Jr −$4.1M Chief Financial Officer sold 82% of stake
- Flynn Sean C. −$779K Chief Legal Officer sold 88% of stake
- MCLAUGHLIN KEVIN F −$413K Director sold 28% of stake
- ZERBE ROBERT L MD −$386K Director sold 19% of stake
- SIEGAL JONATHAN −$79K Principal Accounting Officer sold 54% of stake
Reading 65 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2016-05-04 | MCLAUGHLIN KEVIN F Director | Grant or award · Stock Option (right to buy) | +15,000 | 15,000 | ||
| 2016-05-04 | Hagen Heidi Director | Grant or award · Stock Option (right to buy) | +15,000 | 15,000 | ||
| 2016-05-04 | Rubino Alan L Director | Grant or award · Stock option (right to buy) | +15,000 | 15,000 | ||
| 2016-05-04 | ZERBE ROBERT L MD Director | Grant or award · Stock option (right to buy) | +15,000 | 15,000 | ||
| 2016-05-04 | GILMAN STEVEN C Director | Grant or award · Stock Option (right to buy) | +15,000 | 15,000 | ||
| 2016-05-04 | Wotton Paul K Director | Grant or award · Stock Option (right to buy) | +15,000 | 15,000 | ||
| 2016-03-28 | Consonance Capital Management LP 10% owner | Sale | −120,000 | $5.39 | $647K | 2,232,940 |
| 2016-02-09 | Orlando Daniel Chief Operating Officer | Grant or award · Stock Option (right to buy) | +80,000 | 80,000 | ||
| 2016-02-09 | MICHEL GERARD J CFO and VP, Corp. Development | Grant or award · Stock Option (right to buy) | +80,000 | 80,000 | ||
| 2016-02-09 | Colangelo Dominick President and CEO | Grant or award · Stock Option (right to buy) | +165,000 | 165,000 | ||
| 2015-03-20 | MCLAUGHLIN KEVIN F Director | Grant or award · Stock Option (right to buy) | +20,000 | 20,000 | ||
| 2015-03-20 | SIMS NELSON M Director | Grant or award · Stock Option (right to buy) | +19,000 | 19,000 | ||
| 2015-03-20 | Hagen Heidi Director | Grant or award · Stock Option (right to buy) | +19,000 | 19,000 | ||
| 2015-03-20 | GILMAN STEVEN C Director | Grant or award · Stock Option (right to buy) | +20,000 | 20,000 | ||
| 2015-03-20 | Rubino Alan L Director | Grant or award · Stock Option (right to buy) | +19,000 | 19,000 | ||
| 2015-03-20 | Wotton Paul K Director | Grant or award · Stock Option (right to buy) | +20,000 | 20,000 | ||
| 2015-03-20 | ZERBE ROBERT L MD Director | Grant or award · Stock Option (right to buy) | +19,000 | 19,000 | ||
| 2015-01-05 | Colangelo Dominick President and CEO | Grant or award · Stock option (right to buy) | +440,000 | $3.02 | $1.3M | 440,000 |
| 2015-01-05 | MICHEL GERARD J CFO and VP, Corp. Development | Grant or award · Stock option (right to buy) | +180,000 | $3.02 | $544K | 180,000 |
| 2015-01-05 | Orlando Daniel Chief Operating Officer | Grant or award · Stock Option (right to buy) | +192,000 | $3.02 | $580K | 192,000 |
Page 67 of 75 · 1,497 trades